Thematic Centers of Excellence
Celgene is committed to improving outcomes for patients with cancer through our dedication to innovative science and translational research. The key therapeutic platforms currently under investigation leverage a broad range of biological activities that allow for the development of novel paradigm-changing therapeutics. Our areas of active research include epigenetics, immuno-oncology, protein homeostasis, biotherapeutics, and novel targets. Through advances in these fundamental areas, we will continue to address significant unmet needs, as well as provide physicians and clinicians with new options for managing patients and improving their quality of life.